Downregulation of SENP1 inhibits cell proliferation, migration and promotes apoptosis in human glioma cells

Zhang,Qiu‑Sheng; Zhang,Meng; Huang,Xian‑Jian; Liu,Xiao‑Jia; Li,Wei‑Ping

doi:10.3892/ol.2016.4558

Downregulation of SENP1 inhibits cell proliferation, migration and promotes apoptosis in human glioma cells

Authors:
- Qiu‑Sheng Zhang
- Meng Zhang
- Xian‑Jian Huang
- Xiao‑Jia Liu
- Wei‑Ping Li
View Affiliations

Affiliations: Department of Neurosurgery, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China
Published online on: May 12, 2016 https://doi.org/10.3892/ol.2016.4558
Pages: 217-221

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Small ubiquitin-related modifier protein (SUMO) is an evolutionarily conserved protein in a broad range of eukaryotic organisms. De‑SUMOylation, the reverse reaction of SUMOylation, is regulated by a family of SUMO‑specific proteases (SENPs). SENP1 is a member of the de‑SUMOylation protease family involved in the de‑SUMOylation of a variety of SUMOylated proteins. The present study demonstrates that small hairpin RNA (shRNA)‑mediated downregulation of SENP1 inhibits cell proliferation and migration, and promotes apoptosis in human glioma cells. Firstly, LN‑299 cells were transfected with a plasmid expressing SENP1 shRNA (pGenesil‑1‑SENP1). The messenger RNA and protein expression of SENP1 was detected by reverse transcription‑quantitative polymerase chain reaction and western blot analysis, respectively. Cell proliferation in vitro was assessed using a methyl thiazolyl tetrazolium assay. Flow cytometry (FCM) was used to detect the apoptosis of LN‑299 cells. The effect of the downregulation of SENP1 on cell migration was detected by a Transwell migration system. The present results showed that, compared with the control shRNA group, the expression of SENP1 was significantly reduced in the SENP1 shRNA group. The proliferation was markedly inhibited in the SENP1 shRNA group. FCM findings revealed that apoptosis increased significantly in the SENP1 shRNA group. In addition, it was found that downregulation of SENP1 evidently suppressed tumor cell migration. Downregulation of SENP1 expression inhibited the proliferation and migration and promoted apoptosis in LN‑299 cells. These results indirectly demonstrate that SENP1 is likely to play a critical role in human glioma cells.

View Figures

View References

1	Geiss-Friedlander R and Melchior F: Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol. 8:947–956. 2007. View Article : Google Scholar : PubMed/NCBI
2	Hay RT: SUMO: A history of modification. Mol Cell. 18:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
3	Yeh ET, Gong L and Kamitani T: Ubiquitin-like proteins: New wines in new bottles. Gene. 248:1–14. 2000. View Article : Google Scholar : PubMed/NCBI
4	Gill G: SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev. 18:2046–2059. 2004. View Article : Google Scholar : PubMed/NCBI
5	Saitoh H: The role of ubiquitin-like protein SUMO-1 in the nucleus. Tanpakushitsu Kakusan Koso. 44(12 Suppl): 1852–1859. 1999.(In Japanese). PubMed/NCBI
6	Dünnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, et al: Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Int J Cancer. 125:596–602. 2009. View Article : Google Scholar : PubMed/NCBI
7	Hay RT: SUMO-specific proteases: A twist in the tail. Trends Cell Biol. 17:370–376. 2007. View Article : Google Scholar : PubMed/NCBI
8	Hu G, Xu C and Staudinger JL: Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther. 335:342–350. 2010. View Article : Google Scholar : PubMed/NCBI
9	Pourcet B, Pineda-Torra I, Derudas B, Staels B and Glineur C: SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J Biol Chem. 285:5983–5992. 2010. View Article : Google Scholar : PubMed/NCBI
10	Chow KH, Elgort S, Dasso M, Powers MA and Ullman KS: The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function. Mol Biol Cell. 25:160–168. 2014. View Article : Google Scholar : PubMed/NCBI
11	Wang Q, Xia N, Li T, Xu Y, Zou Y, Zuo Y, Fan Q, Bawa-Khalfe T, Yeh ET and Cheng J: SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene. 32:2493–2498. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sanna K, Tiina J, Ulla K, Rytinki MM, Makkonen H, Gioeli D, Paschal BM and Palvimo JJ: SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol Endocrinol. 23:292–307. 2009. View Article : Google Scholar : PubMed/NCBI
13	Cheng J, Bawa T, Peng L, Lee P, Gong L and Yeh ET: Role of desumoylation in the development of prostate cancer. Neoplasia. 8:667–676. 2006. View Article : Google Scholar : PubMed/NCBI
14	Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM and Yeh ET: SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem. 285:25859–25866. 2010. View Article : Google Scholar : PubMed/NCBI
15	Dammer EB, Leon A and Sewer MB: Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54 and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol Endocrinol. 21:415–438. 2007. View Article : Google Scholar : PubMed/NCBI
16	Lee WP, Jena S, Doherty D, Ventakesh J, Schimdt J, Furmick J, Widener T, Lemau J, Jurutka PW and Thompson PD: SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling. PLoS One. 9:e895062014. View Article : Google Scholar : PubMed/NCBI
17	Qi L, Wang WY, Zheng ZH, Zhang YH, Zhao L, Zhong XH, Zhao DH, Yang S, Yang NJ and Ren K: Effects of SUMO and proteins modified by SUMO on occurrence of malignant gliomas. Ji Lin Da Xue Xue Bao. 42:7–10. 2016.(In Chinese).
18	Chen J, Gao Q, Wang XY, et al: Protein expression and significance of SENP1 and HER-2 in the gastric cancer. Chinese Journal of Current Advances in General Surgery. 16:102–106. 2013.
19	Zhang W, Sun H, Shi X, Wang H, Cui C, Xiao F, Wu C, Guo X and Wang L: SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma. Tumor Biol. Dec 22–2015.(Epub ahead of print).
20	Ma C, Wu B, Huang X, Yuan Z, Nong K, Dong B, Bai Y, Zhu H, Wang W and Ai K: SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. Tumour Biol. 35:12729–12735. 2014. View Article : Google Scholar : PubMed/NCBI